Mwandishi:
Mhariri:
ULY CLINIC
Dkt. Benjamin L, MD
16 Machi 2021 16:34:31
Dimenhydrinate na ujauzito
Kwa ujumla dawa jamii ya antihistamine zimeonekana kutokuwa na hatari ya kusababisha madhaifu ya kiuumbaji kwa watoto wanaozaliwa na wamama waliotumia dawa hii. Hata hivyo matumizi kwa wajawazito karibia na kujifungua kabla ya wakati kufika huhusiana na kusababisha fibroplasia ya retrolental.
Ushauri dhidi ya matumizi kwa mama mjamzito
Inapatana na ujauzito
Inapatana na ujauzito maana yake nini?
Uzoefu wa matumizi kwa binadamu kuhusu dawa hii au dawa zingine zilizo kundi moja au zenye kufanya kazi kwa utaratibu unaofanana, zinatosha kuonyesha kuwa, madhara kwa kichanga tumboni ni madogo sana au hakuna kabisa. Tafiti za uzazi kwa wanyama hazina uhalisia kwa binadamu.
Ushauri wa matumizi kwa mama anayenyonyesha
Hakuna (chache) taarifa za binadamu- Inawezekana patana na unyonyeshaji
Hakuna (chache) taarifa za binadamu- Inawezekana patana na unyonyeshaji maana yake nini?
Hakuna taarifa za uzoefu kuhusu matumizi ya dawa hii kwa mama anayenyonyesha au kuna taarifa chache. Taarifa chache zilizopo zinaonyesha kuwa dawa hii haiwasilishi hatari yenye mashiko kwa kichanga anayenyonya maziwa ya mama anayetumia dawa.
ONYO: Usitumie dawa yoyote bila ushauri wa daktari. Dawa zinaweza kuleta madhara mwilini na pia matumizi ya baadhi ya dawa pasipo ushauri na vipimo husababisha vimelea kuwa sugu dhidi ya dawa hiyo.
ULY clinic inakushauri kuwasiliana na daktari wako unapotaka kuchukua maamuzi yoyote yanayohusu afya yako.
Wasiliana na daktari/Mfamasia wa ULY clinic kwa ushauri na Tiba au kuandikiwa dawa kwa kupiga simu au Kubonyeza Pata tiba chini ya tovuti hii.
Imeboreshwa,
1 Julai 2023 17:21:36
Rejea za mada hii
1. Mellin GW, et al. Meclozine and fetal abnormalities. Lancet 1963;1:222–3.
2. Heinonen OP, et al. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group, 1977.
3. Watt LO. Oxytocic effects of dimenhydrinate in obstetrics. Can Med Assoc J 1961;84:533–4.
4. Rotter CW, et al. The use of intravenous Dramamine to shorten the time of labor and potentiate analgesia. Am J Obstet Gynecol 1958:75:1101–4.
5. Scott RS, et al. Use of dimenhydrinate in labor. Am J Obstet Gynecol 1962;83:25–8.
6. Humphreys DW. Safe relief of pain during labor with dimenhydrinate. Clin Med (Winnetka) 1962;69:1165–8.
7. Cooper K. Failure of dimenhydrinate to shorten labor. Am J Obstet Gynecol 1963;86:1041–3.
8. Harkins JL, et al. A clinical evaluation of intravenous dimenhydrinate in labor. Can Med Assoc J 1964;91:164–6.
9. Scott RS. The use of intravenous dimenhydrinate in labor. New Physician 1964;13:302–7.
10. Klieger JA, et al. Clinical and laboratory survey into the oxytocic effects of dimenhydrinate inlabor. Am J Obstet Gynecol 1965;92:1–10.
11. Hay TB, et al. The effect of dimenhydrinate on uterine contractions. Aust NZ J Obstet Gynaecol1967;1:81–9.
12. Shephard B, et al. The acute effects of Dramamine on uterine contractibility duringlabor. J Reprod Med 1976;16:27–8.
13. Hara GSet al. Dramamine in labor: potential boon or a possible bomb? J Kans Med Soc 1980;81:134–6, 155.
14. Gross S, et al. Maternal weight loss associate with hyperemesis gravidarum: a predictor of fetal outcome. Am J Obstet Gynecol 1989;160:906–9.